自身反应性与自身免疫:类风湿关节炎与健康人中自身抗原特异性CD4 T细胞的特征
该研究基于英国早期关节炎队列,利用MHC II类肽四聚体结合光谱流式细胞术,比较了HLA-DRB1*04:01阳性健康对照、不同疾病阶段的RA患者及高危个体的瓜氨酸肽特异性CD4 T细胞。发现各组自身反应性T细胞频率无显著差异,但健康对照中以初始T细胞为主,而早期未治疗RA中自身反应性记忆T细胞下调CD27和CD28并表达CX3CR1,提示体内激活和潜在细胞毒性能力,治疗后CD27阴性自身反应性细胞比例下降。
要点
- RA中瓜氨酸肽特异性CD4 T细胞呈现CD27/CD28下调及CX3CR1表达的记忆表型。
- 健康对照中自身反应性T细胞以初始表型为主,频率与RA无显著差异。
- 治疗后CD27阴性自身反应性细胞比例下降,部分高危个体RA发病前已出现RA相关特征。
核心结论
- RA中CD4 T细胞自身反应性以提示体内激活和潜在细胞毒性能力的表面表型为特征,而健康自身反应性表现为初始状态。
- 这些观察提示RA中自身反应性在成熟,并可能为监测疾病进展和耐受提供新工具。
研究设计与样本
- 研究纳入HLA-DRB1*04:01阳性健康对照9例、不同疾病阶段的RA患者17例(未治疗)和13例(治疗中)以及6例高危个体。
- 采用MHC II类肽四聚体结合光谱流式细胞术评估瓜氨酸肽特异性(自身反应性)CD4 T细胞频率和表型,重点关注记忆CD4 T细胞区室。
主要发现
- 比较组间自身反应性T细胞频率无统计学显著差异。
- 健康对照中自身反应性T细胞更可能为初始表型。
- 早期未治疗RA中自身反应性记忆T细胞显示CD27和CD28下调并表达趋化因子受体CX3CR1,这些特征与CD4细胞毒性相关。
- 治疗后CD27阴性自身反应性细胞比例下降。
- 部分高危个体在RA发病前已出现RA相关特征。
临床怎么用
- 瓜氨酸肽特异性CD4 T细胞的CD27/CD28下调及CX3CR1表达可能作为监测RA疾病进展和耐受状态的候选免疫标志物。
局限性
- 研究样本量较小(健康对照9例、未治疗RA 17例、治疗中RA 13例、高危个体6例),结论需更大队列验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: CD4 T cells specific for citrullinated (cit) peptides are key players in rheumatoid arthritis (RA) immunopathogenesis. Characterizing these cells and identifying features of healthy and RA-associated autoreactivity will provide valuable insight into disease mechanisms and form the basis of immune state biomarkers to facilitate the next generation of RA treatments. We sought to characterize these cells in a UK early arthritis cohort. METHODS: Cit-peptide-specific (autoreactive) CD4 T cells from human leukocyte antigen (HLA)-DRB1 04:01-positive healthy controls (HCs; n = 9), patients with RA at different disease stages (n = 17 pretreatment and 13 receiving treatment), and six at-risk individuals were assessed using major histocompatibility complex II peptide tetramers combined with spectral flow cytometry. Autoreactive T cell frequency and phenotype were studied, with a particular focus on the memory CD4 T cell compartment. RESULTS: There was no statistically significant difference in autoreactive T cell frequency between comparator groups. In HCs, however, autoreactive T cells were more likely to be naive. In early pretreatment RA, autoreactive memory T cells demonstrated down-regulation of CD27 and CD28 and expression of the fractalkine receptor CX3CR1, features that have been linked to CD4 cytotoxicity. The proportion of CD27-negative autoreactive cells decreased following treatment, and RA-associated features were evident in some at-risk donors before RA onset. CONCLUSION: In RA, CD4 T cell autoreactivity is characterized by a surface phenotype that suggests in vivo activation and the potential to acquire cytotoxic capacity, whereas healthy autoreactivity demonstrates naivety. These observations suggest maturing autoreactivity in RA and may provide novel tools for monitoring disease progression and tolerance.
引用
- Stanway JA, Peters D, Waller H, et al. Autoreactivity Versus Autoimmunity: Characteristics of Autoantigen-Specific CD4 T Cells in Rheumatoid Arthritis and Health. Arthritis Rheumatol. 2026. PMID: 42223208. doi:10.1002/art.70235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。